{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:58:22Z","timestamp":1787029102851,"version":"build-2736575974"},"reference-count":125,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Colorado State University"},{"name":"MDPI"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>A comprehensive understanding of the mechanisms involved in epigenetic changes in gene expression is essential to the clinical management of diseases linked to the SMYD family of lysine methyltransferases. The five known SMYD enzymes catalyze the transfer of donor methyl groups from S-adenosylmethionine (SAM) to specific lysines on histones and non-histone substrates. SMYDs family members have distinct tissue distributions and tissue-specific functions, including regulation of development, cell differentiation, and embryogenesis. Diseases associated with SMYDs include the repressed transcription of SMYD1 genes needed for the formation of ion channels in the heart leading to heart failure, SMYD2 overexpression in esophageal squamous cell carcinoma (ESCC) or p53-related cancers, and poor prognosis associated with SMYD3 overexpression in more than 14 types of cancer including breast cancer, colon cancer, prostate cancer, lung cancer, and pancreatic cancer. Given the importance of epigenetics in various pathologies, the development of epigenetic inhibitors has attracted considerable attention from the pharmaceutical industry. The pharmacologic development of the inhibitors involves the identification of molecules regulating both functional SMYD SET (Suppressor of variegation, Enhancer of Zeste, Trithorax) and MYND (Myeloid-Nervy-DEAF1) domains, a process facilitated by available X-ray structures for SMYD1, SMYD2, and SMYD3. Important leads for potential pharmaceutical agents have been reported for SMYD2 and SMYD3 enzymes, and six epigenetic inhibitors have been developed for drugs used to treat myelodysplastic syndrome (Vidaza, Dacogen), cutaneous T-cell lymphoma (Zoinza, Isrodax), and peripheral T-cell lymphoma (Beleodag, Epidaza). The recently demonstrated reversal of SMYD histone methylation suggests that reversing the epigenetic effects of SMYDs in cancerous tissues may be a desirable target for pharmacological development.<\/jats:p>","DOI":"10.3390\/molecules28042000","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T01:39:28Z","timestamp":1676943568000},"page":"2000","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Targeting Epigenetic Changes Mediated by Members of the SMYD Family of Lysine Methyltransferases"],"prefix":"10.3390","volume":"28","author":[{"given":"Alyssa","family":"Padilla","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences, Colorado State University, Fort Collins, CO 80523-1617, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Manganaro","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Colorado State University, Fort Collins, CO 80523-1872, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Huesgen","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Colorado State University, Fort Collins, CO 80523-1617, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A.","family":"Roess","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Colorado State University, Fort Collins, CO 80523-1617, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Brown","sequence":"additional","affiliation":[{"name":"Cell and Molecular Biology Program, Colorado State University, Fort Collins, CO 80523-1005, USA"},{"name":"Department of Clinical Sciences, Colorado State University, Fort Collins, CO 80523-1678, USA"},{"name":"Graduate Degree Program in Ecology, Department of Ethnic Studies, Global Health and Health Disparities, Colorado School of Public Health, Colorado State University, Fort Collins, CO 80523-1612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7792-3450","authenticated-orcid":false,"given":"Debbie C.","family":"Crans","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Colorado State University, Fort Collins, CO 80523-1872, USA"},{"name":"Cell and Molecular Biology Program, Colorado State University, Fort Collins, CO 80523-1005, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3390\/genes2010210","article-title":"SET\/MYND Lysine Methyltransferases Regulate Gene Transcription and Protein Activity","volume":"2","author":"Leinhart","year":"2011","journal-title":"Genes"},{"key":"ref_2","first-page":"55","article-title":"Characterization of the SMYD Family of Lysine Methyltransferases: Reflections upon Key Findings and Therapeutic Implications","volume":"4","author":"Edwards","year":"2015","journal-title":"Int. J. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e07387","DOI":"10.1016\/j.heliyon.2021.e07387","article-title":"The SMYD family proteins in immunology: An update of their obvious and non-obvious relations with the immune system","volume":"7","year":"2021","journal-title":"Heliyon"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.bbrc.2022.02.043","article-title":"SMYD5 is a histone H3-specific methyltransferase mediating mono-methylation of histone H3 lysine 36 and 37","volume":"599","author":"Aljazi","year":"2022","journal-title":"Biochem. Biophys Res. Commun."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1038\/s41467-022-30940-1","article-title":"SMYD5 catalyzes histone H3 lysine 36 trimethylation at promoters","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.cophys.2017.10.001","article-title":"The Smyd Family of Methyltransferases: Role in Cardiac and Skeletal Muscle Physiology and Pathology","volume":"1","author":"Tracy","year":"2018","journal-title":"Curr. Opin. Physiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3892\/ijo.2020.5095","article-title":"SMYD3 overexpression indicates poor prognosis and promotes cell proliferation, migration and invasion in non-small cell lung cancer","volume":"57","author":"Li","year":"2020","journal-title":"Int. J. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.2174\/1389450121666200325093104","article-title":"Epigenetic Therapies and Potential Drugs for Treating Human Cancer","volume":"21","author":"Lin","year":"2020","journal-title":"Curr. Drug Targets"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13148-019-0711-4","article-title":"Histone methyltransferase SMYD2: Ubiquitous regulator of disease","volume":"11","author":"Yi","year":"2019","journal-title":"Clin. Epigenetics"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1074\/mcp.M700271-MCP200","article-title":"The Tale of Two Domains: Proteomics and Genomics Analysis of SMYD2, A New Histone Methyltransferase","volume":"7","author":"Lambert","year":"2008","journal-title":"Mol. Cell Proteo."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1126\/science.1192428","article-title":"Genomic comparison of the ants Camponotus floridanus and Harpegnathos saltator","volume":"329","author":"Bonasio","year":"2010","journal-title":"Science"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Yang, L., Jin, M., and Jeong, K.W. (2021). Histone H3K4 Methyltransferases as Targets for Drug-Resistant Cancers. Biology, 10.","DOI":"10.3390\/biology10070581"},{"key":"ref_13","first-page":"366","article-title":"Role of somatic cancer mutations in human protein lysine methyltransferases","volume":"1846","author":"Kudithipudi","year":"2014","journal-title":"Biochim. Biophy Acta"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Bottino, C., Peserico, A., Simone, C., and Caretti, G. (2020). SMYD3: An Oncogenic Driver Targeting Epigenetic Regulation and Signaling Pathways. Cancers, 12.","DOI":"10.3390\/cancers12010142"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ejmech.2019.01.069","article-title":"Histone methyl transferases: A class of epigenetic opportunities to counter uncontrolled cell proliferation","volume":"166","author":"Singh","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"E7871","DOI":"10.1073\/pnas.1800680115","article-title":"Histone methyltransferase Smyd1 regulates mitochondrial energetics in the heart","volume":"115","author":"Warren","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Wang, Z., Schwartz, R.J., Liu, J., Sun, F., Li, Q., and Ma, Y. (2021). Smyd1 Orchestrates Early Heart Development Through Positive and Negative Gene Regulation. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.654682"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ydbio.2015.12.005","article-title":"Defective myogenesis in the absence of the muscle-specific lysine methyltransferase SMYD1","volume":"410","author":"Nagandla","year":"2016","journal-title":"Dev. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.leukres.2014.01.013","article-title":"SMYD2 is highly expressed in pediatric acute lymphoblastic leukemi and constitutes a bad prognotic factor","volume":"38","author":"Sakamoto","year":"2014","journal-title":"Leuk. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1002\/ar.22972","article-title":"SMYD proteins: Key regulators in skeletal and cardiac muscle development and function","volume":"297","author":"Du","year":"2014","journal-title":"Anat. Rec."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1126\/science.1063127","article-title":"Translating the histone code","volume":"293","author":"Jenuwein","year":"2001","journal-title":"Science"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0959-437X(02)00287-3","article-title":"Histone methylation in transcriptional control","volume":"12","author":"Kouzarides","year":"2002","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1476-4598-5-26","article-title":"Identification and characterization of Smyd2: A split SET\/MYND domain-containing histone H3 lysine 36-specific methyltransferase that interacts with the Sin3 histone deacetylase complex","volume":"5","author":"Brown","year":"2006","journal-title":"Mol. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e00341-19","DOI":"10.1128\/MCB.00341-19","article-title":"Function of the MYND Domain and C-Terminal Region in Regulating the Subcellular Localization and Catalytic Activity of the SMYD Family Lysine Methyltransferase Set5","volume":"40","author":"Jaiswal","year":"2020","journal-title":"Mol. Cell Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/bies.200900197","article-title":"Deciphering the genome\u2019s regulatory code: The many languages of DNA","volume":"32","author":"Rister","year":"2010","journal-title":"Bioessays"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"25309","DOI":"10.1074\/jbc.M101914200","article-title":"Set domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3","volume":"276","author":"Tachibana","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1105\/tpc.107.056879","article-title":"High-resolution mapping of epigenetic modifications of the rice genome uncovers interplay between DNA methylation, histone methylation, and gene expression","volume":"20","author":"Li","year":"2008","journal-title":"Plant Cell"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"109040","DOI":"10.1016\/j.abb.2021.109040","article-title":"Functions of SMYD proteins in biological processes: What do we know? An updated review","volume":"712","author":"Audano","year":"2021","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.3390\/ijms16011406","article-title":"Structure and function of SET and MYND domain-containing proteins","volume":"16","author":"Spellmon","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.18632\/oncotarget.2970","article-title":"C-terminal domain of SMYD3 serves as a unique HSP90-regulated motif in oncogenesis","volume":"6","author":"Brown","year":"2015","journal-title":"Oncotarget"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Foreman, K.W., Brown, M., Park, F., Emtage, S., Harriss, J., Das, C., Zhu, L., Crew, A., Arnold, L., and Shaaban, S. (2011). Structural and functional profiling of the human histone methyltransferase SMYD3. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0022290"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Jarrell, D.K., Hassell, K.N., Alshiraihi, I., Crans, D.C., and Brown, M.A. (2022). Structural Analysis of SMYD3 Lysine Methyltransferase for the Development of Competitive and Specific Enzyme Inhibitors. Diseases, 10.","DOI":"10.3390\/diseases10010004"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1096\/fj.02-0889com","article-title":"Hallmarks of ion channel gene expression in end-stage heart failure","volume":"17","author":"Borlak","year":"2003","journal-title":"FASEB J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41419-018-0347-x","article-title":"Lysine methyltransferase SMYD2 promotes triple negative breast cancer progression","volume":"9","author":"Li","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/ncb1151","article-title":"SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells","volume":"6","author":"Hamamoto","year":"2004","journal-title":"Nat. Cell Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.canlet.2013.10.026","article-title":"Histone methyltransferase SMYD3 promotes MRTF-A-mediated transactivation of MYL9 and migration of MCF-7 breast cancer cells","volume":"344","author":"Luo","year":"2014","journal-title":"Cancer Lett."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"294","DOI":"10.5483\/BMBRep.2008.41.4.294","article-title":"Knockdown of SMYD3 by RNA interference inhibits cervical carcinoma cell growth and invasion in vitro","volume":"41","author":"Wang","year":"2008","journal-title":"BMB Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1530\/ERC-13-0375","article-title":"Deregulated expression of selected histone methylases and demethylases in prostate carcinoma","volume":"21","author":"Vieira","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.humpath.2011.11.003","article-title":"High expression of trimethylated histone H3 lysine 4 is associated with poor prognosis in hepatocellular carcinoma","volume":"43","author":"He","year":"2012","journal-title":"Hum. Pathol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mce.2014.04.016","article-title":"Epigenetic-related gene expression profile in medullary thyroid cancer revealed the overexpression of the histone methyltransferases EZH2 and SMYD3 in aggressive tumours","volume":"392","author":"Sponziello","year":"2014","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1007\/s12031-022-02051-5","article-title":"STUB1-SMYD2 Axis Regulates Drug Resistance in Glioma cells","volume":"72","author":"Pan","year":"2022","journal-title":"J. Mol. Neurosci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1002\/jcp.24975","article-title":"A SMYD3 Small-Molecule Inhibitor Impairing Cancer Cell Growth","volume":"230","author":"Peserico","year":"2015","journal-title":"J. Cell Physiol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Alshiraihi, I.M., Jarrell, D.K., Arhouma, Z., Hassell, K.N., Montgomery, J., Padilla, A., Ibrahim, H.M., Crans, D.C., Kato, T.A., and Brown, M.A. (2020). In Silico\/In Vitro Hit-to-Lead Methodology Yields SMYD3 Inhibitor That Eliminates Unrestrained Proliferation of Breast Carcinoma Cells. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21249549"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1021\/acsmedchemlett.9b00170","article-title":"Discovery of Irreversible Inhibitors Targeting Histone Methyltransferase, SMYD3","volume":"10","author":"Huang","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.str.2011.06.011","article-title":"Structural basis of substrate methylation and inhibition of SMYD2","volume":"19","author":"Ferguson","year":"2011","journal-title":"Structure"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1021\/acsmedchemlett.5b00272","article-title":"Novel Oxindole Sulfonamides and Sulfamides: EPZ031686, the First Orally Bioavailable Small Molecule SMYD3 Inhibitor","volume":"7","author":"Mitchell","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Suraweera, A., O\u2019Byrne, K.J., and Richard, D.J. (2018). Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi. Front. Oncol., 8.","DOI":"10.3389\/fonc.2018.00092"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2147\/tcrm.2006.2.4.377","article-title":"Azacytidine (Vidaza(R)) in the treatment of myelodysplastic syndromes","volume":"2","author":"Raj","year":"2006","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1634\/theoncologist.2015-0298","article-title":"The European Medicines Agency Review of Decitabine (Dacogen) for the Treatment of Adult Patients With Acute Myeloid Leukemia: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use","volume":"21","author":"Nieto","year":"2016","journal-title":"Oncologist"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4103\/0019-5154.160511","article-title":"Vorinostat-An Overview","volume":"60","author":"Bubna","year":"2015","journal-title":"Indian J. Derm."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/ja.2011.35","article-title":"Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): A natural product recently approved for cutaneous T-cell lymphoma","volume":"64","author":"VanderMolen","year":"2011","journal-title":"J. Antibiot."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1177\/2040620715592567","article-title":"Belinostat in patients with refractory or relapsed peripheral T-cell lymphoma: A perspective review","volume":"6","author":"Sawas","year":"2015","journal-title":"Ther. Adv. Hematol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"605","DOI":"10.21147\/j.issn.1000-9604.2018.06.05","article-title":"Exploratory clinical study of chidamide, an oral subtype-selective histone deacetylase inhibitor, in combination with exemestane in hormone receptor-positive advanced breast cancer","volume":"30","author":"Zhang","year":"2018","journal-title":"Chin. J. Cancer Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1021\/ml400496h","article-title":"Discovery and Development of Potent and Selective Inhibitors of Histone Methyltransferase G9a","volume":"5","author":"Sweis","year":"2014","journal-title":"ACS Medl. Chem. Lett."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"13641","DOI":"10.1074\/jbc.M114.626861","article-title":"LLY-507, a Cell-active, Potent, and Selective Inhibitor of Protein-lysine Methyltransferase SMYD2","volume":"290","author":"Nguyen","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"214143","DOI":"10.1016\/j.ccr.2021.214143","article-title":"Polyoxovanadates with emerging biomedical activities","volume":"447","author":"Aureliano","year":"2021","journal-title":"Coord. Chem. Rev."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"5805","DOI":"10.1021\/acs.jmedchem.7b01689","article-title":"Ru(II) Compounds: Next-Generation Anticancer Metallotherapeutics?","volume":"61","author":"Thota","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","article-title":"ZINC 15--Ligand Discovery for Everyone","volume":"55","author":"Sterling","year":"2015","journal-title":"J. Chem. Inf. Model"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1158\/0008-5472.CAN-08-4097","article-title":"Identification of Smyd4 as a potential tumor suppressor gene involved in breast cancer development","volume":"69","author":"Hu","year":"2009","journal-title":"Cancer Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1002\/tcr.201800082","article-title":"Mechanisms and inhibitors of histone arginine methylation","volume":"18","author":"Fulton","year":"2018","journal-title":"Chem. Record"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jmgm.2016.07.001","article-title":"Explaining the autoinhibition of the SMYD enzyme family: A theoretical study","volume":"68","author":"Alnabulsi","year":"2016","journal-title":"J. Mol. Graph Model"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"40635","DOI":"10.1074\/jbc.M110.168187","article-title":"Crystal structure of cardiac-specific histone methyltransferase SmyD1 reveals unusual active site architecture","volume":"285","author":"Sirinupong","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Jiang, Y., Sirinupong, N., Brunzelle, J., and Yang, Z. (2011). Crystal structures of histone and p53 methyltransferase SmyD2 reveal a conformational flexibility of the autoinhibitory C-terminal domain. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0021640"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/jmcb\/mjr015","article-title":"Structure of human lysine methyltransferase Smyd2 reveals insights into the substrate divergence in Smyd proteins","volume":"3","author":"Xu","year":"2011","journal-title":"J. Mol. Cell Biol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"146928","DOI":"10.1016\/j.gene.2022.146928","article-title":"The lysine methyltransferases SET and MYND domain containing 2 (Smyd2) and Enhancer of Zeste 2 (Ezh2) co-regulate osteoblast proliferation and mineralization","volume":"851","author":"Dashti","year":"2023","journal-title":"Gene"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jmb.2010.12.014","article-title":"Structural insights into the autoinhibition and posttranslational activation of histone methyltransferase SmyD3","volume":"406","author":"Sirinupong","year":"2011","journal-title":"J. Mol. Biol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cbpb.2016.01.004","article-title":"Molecular characterization and expression regulation of Smyd1a and Smyd1b in skeletal muscle of Chinese perch (Siniperca chuatsi)","volume":"194","author":"Wang","year":"2016","journal-title":"Comp. Biochem. Phys. B- Biochem. Mol. Biol."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Alshammari, E., Sobota, J., Yang, A., Li, C., and Yang, Z. (2022). Unique SMYD5 Structure Revealed by AlphaFold Correlates with Its Functional Divergence. Biomolecules, 12.","DOI":"10.3390\/biom12060783"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"108834","DOI":"10.1016\/j.cbi.2019.108834","article-title":"The anti-cancer drug doxorubicin induces substantial epigenetic changes in cultured cardiomyocytes","volume":"313","author":"Hanf","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"eaal3321","DOI":"10.1126\/science.aal3321","article-title":"A subcellular map of the human proteome","volume":"356","author":"Thul","year":"2017","journal-title":"Science"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Jarrell, D.K., Hassell, K.N., Crans, D.C., Lanning, S., and Brown, M.A. (2020). Characterizing the Role of SMYD2 in Mammalian Embryogenesis-Future Directions. Vet. Sci., 7.","DOI":"10.3390\/vetsci7020063"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.bbamcr.2012.09.012","article-title":"Lysine methyltransferase Smyd2 regulates Hsp90-mediated protection of the sarcomeric titin springs and cardiac function","volume":"1833","author":"Voelkel","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41435-020-0094-8","article-title":"The lysine methyltransferase SMYD2 is required for normal lymphocyte development and survival of hematopoietic leukemias","volume":"21","author":"Brown","year":"2020","journal-title":"Genes Immun."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Diehl, F., Brown, M.A., van Amerongen, M.J., Novoyatleva, T., Wietelmann, A., Harriss, J., Ferrazzi, F., Bottger, T., Harvey, R.P., and Tucker, P.W. (2010). Cardiac deletion of Smyd2 is dispensable for mouse heart development. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0009748"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Thompson, E.C., and Travers, A.A. (2008). A Drosophila Smyd4 homologue is a muscle-specific transcriptional modulator involved in development. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0003008"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/ncb0804-685","article-title":"From chromatin to cancer: A new histone lysine methyltransferase enters the mix","volume":"6","author":"Sims","year":"2004","journal-title":"Nat. Cell Biol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/bjc.2014.543","article-title":"Overexpression of SMYD2 contributes to malignant outcome in gastric cancer","volume":"112","author":"Komatsu","year":"2015","journal-title":"Br. J. Cancer"},{"key":"ref_80","unstructured":"Doughan, M. (2018). SMYD4 Subcellular Localization and Nogo-B Receptor Structure and Function. [Master\u2019s Theses, Wayne State University]."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Xiao, D., Wang, H., Hao, L., Guo, X., Ma, X., Qian, Y., Chen, H., Ma, J., Zhang, J., and Sheng, W. (2018). The roles of SMYD4 in epigenetic regulation of cardiac development in zebrafish. PLoS Genet., 14.","DOI":"10.1371\/journal.pgen.1007578"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Sun, X.J., Xu, P.F., Zhou, T., Hu, M., Fu, C.T., Zhang, Y., Jin, Y., Chen, Y., Chen, S.J., and Huang, Q.H. (2008). Genome-wide survey and developmental expression mapping of zebrafish SET domain-containing genes. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0001499"},{"key":"ref_83","first-page":"314","article-title":"Altered gene expression profiles of histone lysine methyltransferases and demethylases in rheumatoid arthritis synovial fibroblasts","volume":"36","author":"Araki","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"113076","DOI":"10.1016\/j.yexcr.2022.113076","article-title":"SMYD5 acts as a potential biomarker for hepatocellular carcinoma","volume":"414","author":"Chi","year":"2022","journal-title":"Exp. Cell Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13072-017-0115-7","article-title":"SMYD5 regulates H4K20me3-marked heterochromatin to safeguard ES cell self-renewal and prevent spurious differentiation","volume":"10","author":"Kidder","year":"2017","journal-title":"Epigen Chroma"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"6729","DOI":"10.1158\/0008-5472.CAN-17-0828","article-title":"SMYD5 Controls Heterochromatin and Chromosome Integrity during Embryonic Stem Cell Differentiation","volume":"77","author":"Kidder","year":"2017","journal-title":"Cancer Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.molcel.2012.07.020","article-title":"Control of proinflammatory gene programs by regulated trimethylation and demethylation of histone H4K20","volume":"48","author":"Stender","year":"2012","journal-title":"Mol. Cell"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Fujii, T., Tsunesumi, S., Sagara, H., Munakata, M., Hisaki, Y., Sekiya, T., Furukawa, Y., Sakamoto, K., and Watanabe, S. (2016). Smyd5 plays pivotal roles in both primitive and definitive hematopoiesis during zebrafish embryogenesis. Sci. Rep., 6.","DOI":"10.1038\/srep29157"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jgg.2021.03.004","article-title":"Smyd1 is essential for myosin expression and sarcomere organization in craniofacial, extraocular, and cardiac muscles","volume":"48","author":"Jiao","year":"2021","journal-title":"J. Genet. Genom."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1242\/jcs.084772","article-title":"The myosin-interacting protein SMYD1 is essential for sarcomere organization","volume":"124","author":"Just","year":"2011","journal-title":"J. Cell Sci."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Rasmussen, T.L., Ma, Y., Park, C.Y., Harriss, J., Pierce, S.A., Dekker, J.D., Valenzuela, N., Srivastava, D., Schwartz, R.J., and Stewart, M.D. (2015). Smyd1 facilitates heart development by antagonizing oxidative and ER stress responses. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0121765"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"H1234","DOI":"10.1152\/ajpheart.00235.2016","article-title":"The chromatin-binding protein Smyd1 restricts adult mammalian heart growth","volume":"311","author":"Franklin","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.yexcr.2015.06.019","article-title":"skNAC and Smyd1 in transcriptional control","volume":"336","author":"Berkholz","year":"2015","journal-title":"Exp. Cell Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1093\/bbb\/zbab167","article-title":"SMYD1 alleviates septic myocardial injury by inhibiting endoplasmic reticulum stress","volume":"85","author":"Chen","year":"2021","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Chow, M.Z., Sadrian, S.N., Keung, W., Geng, L., Ren, L., Kong, C.W., Wong, A.O., Hulot, J.S., Chen, C.S., and Costa, K.D. (2019). Modulation of chromatin remodeling proteins SMYD1 and SMARCD1 promotes contractile function of human pluripotent stem cell-derived ventricular cardiomyocyte in 3D-engineered cardiac tissues. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-42953-w"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"100129","DOI":"10.1016\/j.bbih.2020.100129","article-title":"The SMYD1 and skNAC transcription factors contribute to neurodegeneratie diseases","volume":"9","author":"Mayfield","year":"2020","journal-title":"Brain Behav. Immun.\u2014Health"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"8377","DOI":"10.7150\/thno.37628","article-title":"Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma","volume":"9","author":"Yan","year":"2019","journal-title":"Theranostics"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.chom.2017.04.011","article-title":"SMYD2-Mediated Histone Methylation Contributes to HIV-1 Latency","volume":"21","author":"Boehm","year":"2017","journal-title":"Cell Host. Microbe"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/jmcb\/mjr025","article-title":"Proteomic analyses of the SMYD family interactomes identify HSP90 as a novel target for SMYD2","volume":"3","author":"Lanouette","year":"2011","journal-title":"J. Mol. Cell Biol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/cns.13587","article-title":"Identification of an epigenetic prognostic signature for patients with lower-grade gliomas","volume":"27","author":"Yu","year":"2021","journal-title":"CNS Neurosci. Ther."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1101\/gad.177758.111","article-title":"Smyd2 controls cytoplasmic lysine methylation of Hsp90 and myofilament organization","volume":"26","author":"Donlin","year":"2012","journal-title":"Genes Dev."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Edwards, M.A., Brown, M.A., Alshiraihi, I., Jarrell, D.K., and Tucker, H.O. (2020). The Lysine Methyltransferase SMYD2 Is Required for Definite Hematopoietic Stem Cell Production in the Mouse Embryo. Vet. Sci., 7.","DOI":"10.3390\/vetsci7030100"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1016\/j.bbamcr.2014.06.019","article-title":"Lysine methyltransferase Smyd2 suppresses p53-dependent cardiomyocyte apoptosis","volume":"1843","author":"Sajjad","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Cao, Y.C., Shan, S.K., Guo, B., Li, C.C., Li, F.X., Zheng, M.H., Xu, Q.S., Wang, Y., Lei, L.M., and Tang, K.X. (2022). Histone Lysine Methylation Modification and Its Role in Vascular Calcification. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.863708"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000495885","article-title":"Amelioration of uremic toxin indoxyl slfate-indced osteroblastic calcification by SET domain containing lysne methytransferase 7\/9 protein","volume":"141","author":"Chen","year":"2019","journal-title":"Nephron"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"297","DOI":"10.11005\/jbm.2021.28.4.297","article-title":"Effects of the Lysine Methyltransferase Inhibitor AZ505 on Bone Metabolism","volume":"28","author":"Song","year":"2021","journal-title":"J. Bone Metab."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1016\/j.jmb.2014.02.019","article-title":"Structural insights into estrogen receptor a methylation by histone methyltransferase SMYD2, a cellular event impliated in estrogen signaling regulation","volume":"426","author":"Jiang","year":"2014","journal-title":"J. Mol. Biol."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Shang, L., and Wei, M. (2019). Inhibition of SMYD2 Sensitized Cisplatin to Resistant Cells in NSCLC Through Activating p53 Pathway. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.00306"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.2147\/OTT.S186806","article-title":"SMYD2-OE promotes oxaliplatin resistance in colon cancer through MDR1\/P-glycoprotein via MEK\/ERK\/AP1 pathway","volume":"12","author":"Ren","year":"2019","journal-title":"Onco. Targets Ther."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Siddique, A.B., Ebrahim, H.Y., Tajmim, A., King, J.A., Abdelwahed, K.S., Abd Elmageed, Z.Y., and El Sayed, K.A. (2022). Oleocanthal Attenuates Metastatic Castration-Resistant Prostate Cancer Progression and Recurrence by Targeting SMYD2. Cancers, 14.","DOI":"10.3390\/cancers14143542"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1200\/JCO.2001.19.22.4224","article-title":"Preoperative chemotherapy in primary operable breast cancer: Results from the European Organization for Research and Treatment of Cancer trial 10902","volume":"19","author":"Julien","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1751-0147-50-27","article-title":"Tumor slices as a model to evaluate doxorubicin in vitro treatment and expression of trios of genes PRSS11, MTSS1, CLPTM1 and PRSS11, MTSS1, SMYD2 in canine mammary gland cancer","volume":"50","author":"Sobral","year":"2008","journal-title":"Acta Vet. Scand."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nature13320","article-title":"SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer","volume":"510","author":"Mazur","year":"2014","journal-title":"Nature"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/bies.201400120","article-title":"Lysine methylation in cancer: SMYD3-MAP3K2 teaches us new lessons in the Ras-ERK pathway","volume":"36","author":"Crespo","year":"2014","journal-title":"Bioessays"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3892\/ol.2021.12603","article-title":"EZH2 and SMYD3 expression in papillary thyroid cancer","volume":"21","author":"Shawkat","year":"2021","journal-title":"Oncol. Lett."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1177\/24725552211019409","article-title":"Discovery of the SMYD3 Inhibitor BAY-6035 Using Thermal Shift Assay (TSA)-Based High-Throughput Screening","volume":"26","author":"Gradl","year":"2021","journal-title":"SLAS Discov."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1021\/acsmedchemlett.9b00493","article-title":"Discovery of Isoxazole Amides as Potent and Selective SMYD3 Inhibitors","volume":"11","author":"Su","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1021\/acs.jmedchem.5b01890","article-title":"Discovery and Characterization of a Highly Potent and Selective Aminopyrazoline-Based in Vivo Probe (BAY-598) for the Protein Lysine Methyltransferase SMYD2","volume":"59","author":"Eggert","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"114683","DOI":"10.1016\/j.ejmech.2022.114683","article-title":"Discovery of the 4-aminopiperidine-based compound EM127 for the site-specific covalent inhibition of SMYD3","volume":"243","author":"Parenti","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ccell.2016.01.013","article-title":"Smyd3 Is a Transcriptional Potentiator of Multiple Cancer-Promoting Genes and Required for Liver and Colon Cancer Development","volume":"29","author":"Sarris","year":"2016","journal-title":"Cancer Cell"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.cell.2005.04.014","article-title":"IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis","volume":"121","author":"Maeda","year":"2005","journal-title":"Cell"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1535-6108(03)00309-X","article-title":"Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse","volume":"4","author":"Hingorani","year":"2003","journal-title":"Cancer Cell"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"101392","DOI":"10.1016\/j.genrep.2021.101392","article-title":"MiR-1307: A comprehensive review of its role in various cancer","volume":"25","author":"Saberianpour","year":"2021","journal-title":"Gene Rep."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"441","DOI":"10.7150\/jca.30041","article-title":"miR-1307-3p Stimulates Breast Cancer Development and Progression by Targeting SMYD4","volume":"10","author":"Han","year":"2019","journal-title":"J. Cancer"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1021\/acs.biochem.5b01129","article-title":"Protein Methyltransferases: A Distinct, Diverse, and Dynamic Family of Enzymes","volume":"55","author":"Swinger","year":"2016","journal-title":"Biochemistry"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/4\/2000\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:37:38Z","timestamp":1760121458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/4\/2000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,20]]},"references-count":125,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["molecules28042000"],"URL":"https:\/\/doi.org\/10.3390\/molecules28042000","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,20]]}}}